ArticlePharmaceuticals (Basel, Switzerland)2019

Radioimmunotherapy in Non-Hodgkin's Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar.

Christos Sachpekidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.